Informed Consent

| Online

View PDF

Add to Outlook Print Share Register Online

Overview

This innovative eLearning module uses a detailed case study and examples taken from actual consent forms to provide an in-depth analysis of, and the key concepts related to, informed consent.

The module also addresses unique situations that do not require consent, alternative methods of communicating consent information to different populations, and changes to informed consent under the Health Insurance Portability and Accountability Act (HIPAA).

Who Should Attend

Physicians
Pharmacists
Physician assistants
Nurse practitioners
Research scientists
Clinical research professionals
Professionals attending DIA training courses who seek supplemental information for use in other courses, such as those dealing with regulations

Learning Objectives

Participants who complete this course should be able to:

Define informed consent and identify the key overall characteristics of the process
Identify situations that would require informed consent, and exceptions to consent
Explain the proper methods of communicating with and gaining consent from various populations of potential study subjects
Identify common problems with completed consent forms
Write a complete and appropriate consent form
Determine which consent form components are necessary based on the characteristics of the study and potential study subjects
Analyze completed consent forms for comprehensiveness, appropriateness, and accuracy
Describe the difference between short and long consent forms, and explain when each is appropriate
Summarize changes to informed consent under HIPAA

The module takes an average of 3.5 hours to complete.

Contact Information

Linda Belmont, DIA
Phone +1.215.293.5818
Linda.Belmont@diahome.org

Technical Requirements

Click here for minimum system requirements.

Continuing Education

ACPE: The Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Drug Information Association designates this educational activity for up to 3.5 contact hours or .35 CEUs. 286-000-11-037-H04-P Type of Activity: Application

Release Date: March 1, 2005
Reviewed and Updated: February 27, 2006
Reviewed and Updated: February 27, 2007
Reviewed and Updated: February 12, 2008
Reviewed and Updated: February 1, 2011
Expiration Date: February 1, 2014 *

*Continuing education credit is available to participants who successfully complete the eLearning program before the expiration date. Once the continuing education credit expires, participants may not be able to receive continuing educations credits; however, participants will continue to have access to this program.

Name	Credit Type	Max Credits	CEU
Informed Consent	ACPE	3.50	0.350

Disclosure Policy:

It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Disclosure statements will be included in the course materials.

Statement of Credit:

In order to receive any continuing education credit for this module, you must complete the module and pass the module exam by midnight on the expiration date. You can still access the module for up to one year from date of registration.

Registration Fees

Other Fees

Individual: $249.00

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.